The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome

Abstract Background Although immune modulation is a promising therapeutic avenue in coronavirus disease 2019 (COVID-19), the most relevant targets remain to be found. COVID-19 has peculiar characteristics and outcomes, suggesting a unique immunopathogenesis. Methods Thirty-six immunocompetent non-CO...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Mathieu Blot, Jean-Baptiste Bour, Jean Pierre Quenot, Abderrahmane Bourredjem, Maxime Nguyen, Julien Guy, Serge Monier, Marjolaine Georges, Audrey Large, Auguste Dargent, Alexandre Guilhem, Suzanne Mouries-Martin, Jeremy Barben, Belaid Bouhemad, Pierre-Emmanuel Charles, Pascal Chavanet, Christine Binquet, Lionel Piroth, for the LYMPHONIE study group
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2020-12-01
Edice:	Journal of Translational Medicine
Témata:	COVID-19 Acute respiratory distress syndrome Pneumonia Immune response CXCL10 GM-CSF
On-line přístup:	https://doi.org/10.1186/s12967-020-02646-9
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!